Metacognitive Therapy Compared to Cognitive-behavioral Therapy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKarolinska Institutet
About this trial
This is a qualitative study of participants who have taken part in a randomized controlled trial comparing transdiagnostic metacognitive therapy and disorder-specific cognitive-behavioral therapy for anxiety disorders. The purpose of the study is to explore participant perceptions of the respective treatment models to facilitate implementation and dissemination of the treatments.
Eligibility criteria
Qualifiers
Age 18 years or older,
A principal diagnosis of generalized anxiety disorder, social anxiety disorder, or posttraumatic stress disorder,
No change in dose during the last six weeks if on pharmacological treatment, and
Ability to read and speak Swedish.
Disqualifiers
A current diagnosis of psychotic disorder, bipolar disorder, neurocognitive disorder, or moderate to severe substance use disorder,
Acute suicide risk, or
Concurrent psychological treatment.
Trial design
Treatments tested in this trial
- Transdiagnostic metacognitive therapy
- Disorder-specific cognitive-behavioral therapy
Treatment groups
30 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov